Pfizer: Pulmonary Disease, Chronic Obstructive trials
The registry lists 22 Pulmonary Disease, Chronic Obstructive studies with Pfizer as lead sponsor. 2 are open to participants now and 5 have results posted.
Phase 1 6Phase 2 12Phase 3 3No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of TimeRecruitingNCT07839884Phase 3
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07363694Phase 2/3
- Immunization To Prevent Acute COPD ExacerbationsTerminatedNCT03276754Results posted
- An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary DiseaseTerminatedNCT02366637Phase 2Results posted
- A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01033487Phase 2Results posted
- Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.TerminatedNCT00430300Phase 2Results posted
- A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPDTerminatedNCT00138671Phase 3Results posted
- The Bioavailability of a Spray Dried Dispersion Solid Dose Formulation of PF-06260414 Relative to a Suspension FormulationWithdrawnNCT02393807Phase 1
- PH-797804 LPS Study in Healthy VolunteersCompletedNCT02084485Phase 1
- Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium BromideCompletedNCT01543919Phase 2
- A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In VolunteersCompletedNCT01364519Phase 1
- Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate CombinationCompletedNCT01321463Phase 2
- Single Dose Lipopolysaccharide (LPS) Study In Healthy VolunteersCompletedNCT01314885Phase 1
- Assessment Of The Inhalation Profiles Of Four Dry Powder Inhalers In Patients With Variable Degrees Of Lung ObstructionCompletedNCT01033669
- Multiple Dose Healthy Volunteer Safety Pharmacokinetics StudyCompletedNCT00864786Phase 1
- A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT00808288Phase 2
- Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.CompletedNCT00783406Phase 2
- A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00559910Phase 2
- A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD PatientsTerminatedNCT00472264
- Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPDTerminatedNCT00263874Phase 2
- A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00219622Phase 2
- A Study of UK-369,003 on the Safety and Efficacy in Patients With COPDCompletedNCT00163098Phase 1/2